Warning letterPosted November 10, 2026

FDA warning letter to Penn Herb Company, Ltd.

CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated

FDA's record ↗

FDA posted a warning letter to Penn Herb Company, Ltd. on November 10, 2026; the letter is dated October 19, 2026. Subject: CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated. Issuing office: Human Foods Program.

On the record

Company
Penn Herb Company, Ltd.
Subject
CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated
Issuing office
Human Foods Program
Letter dated
2026-10-19
Posted by FDA
2026-11-10
Source
FDA warning letters ↗

CFR cited

The record cites 3 sections of 21 CFR Part 111.

The full record

An account shows the violations FDA described and each CFR section it cited.

What a warning letter is

A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.

More

Watch Penn Herb Company, Ltd

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA warning letters. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Penn Herb Company, Ltd.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.